Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
tivozanib 1.34 MG Oral Capsule [Fotivda]
1.34 MG · Oral Capsule · oral
A form of tivozanib →
tivozanib 1.34 MG Oral Capsule [Fotivda] — Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Strength, form, class, interactions & more.
![tivozanib 1.34 MG Oral Capsule [Fotivda]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=de77155c-ecf2-4f15-9758-21d271449d83&name=fotivda-01.jpg)
Active ingredient
Classification
Drug interactions
Tivozanib should not be used with strong CYP3A inducers due to reduced exposure and potential decrease in anti-tumor activity.
- majorstrong CYP3A inducers — decreases tivozanib exposure and may reduce anti-tumor activity
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication